Western blotting analysis of antibodies to prostate-specific antigen: Cross-reactivity with human kallikrein-2

Tumor Biology

Volumn 20, Issue SUPPL. 1, 1999, Pages 75-78

  Wang, Tang J ^a   Linton, H J ^a   Rittenhouse, H G ^a   Wolfert, R L ^a  

^a Hybritech Incorporated   (United States)

Author keywords

Antibodies; ISOBM; Kallikrein 2; Prostate specific antigen; TD 3 Workshop

Indexed keywords

EPITOPE; KALLIKREIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 11E5C6; MONOCLONAL ANTIBODY 12C11C3; MONOCLONAL ANTIBODY 19D5; MONOCLONAL ANTIBODY 4H5; MONOCLONAL ANTIBODY 5C7; MONOCLONAL ANTIBODY 5E4; MONOCLONAL ANTIBODY 5P151; MONOCLONAL ANTIBODY 7P401; MONOCLONAL ANTIBODY 8311; MONOCLONAL ANTIBODY 92 283; MONOCLONAL ANTIBODY 93 251; MONOCLONAL ANTIBODY A67 C F10; MONOCLONAL ANTIBODY E72; MONOCLONAL ANTIBODY F5; MONOCLONAL ANTIBODY H117; MONOCLONAL ANTIBODY H50; MONOCLONAL ANTIBODY M28084; MONOCLONAL ANTIBODY M704; MONOCLONAL ANTIBODY MP2; MONOCLONAL ANTIBODY PCS4; MONOCLONAL ANTIBODY PD1F215; MONOCLONAL ANTIBODY PF1D039; MONOCLONAL ANTIBODY PF1D040; MONOCLONAL ANTIBODY PSR217; PROSTATE SPECIFIC ANTIGEN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIGEN BINDING; CONFERENCE PAPER; CROSS REACTION; EPITOPE MAPPING; IMMUNOBLOTTING; IMMUNOREACTIVITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0032732065     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000056533     Document Type: Conference Paper

References (9)

1. Young CYF, Andrews PE, Montgomery BT, Tindall DJ: Tissue specific and hormonal regulation of human glandular kallikrein. Biochemistry 1992;31:818-824.
2. Deperthes D, Chapdelaine P, Tremblay RR, Brunet C, Berton J, Hebert J, Lazure C, Dube JY: Isolation of prostatic kallikrein hK2, also known as hGK-1, in human seminal plasma. Biochim Biophys Acta 1995; 1245:311-316.
3. Grauer L, Charlesworth MC, Saedi MS, Finlay JA, Liu R-S, Kuus-Reichel K, Tindall DJ: Identification of human glandular kallikrein (hK2) from LNCaP cells. J Androl 1996; 17:353-359.
4. Finlay JA, Evans CL, Day JR, Payne JK, Mikolajczyk SD, Millar LS, Kuus-Reichel K, Wolfert RL, Rittenhouse HG: Development of monoclonal antibodies specific for human glandular kallikrein (hK2): Development of a dual antibody immunoassay for hK2 with negligible prostate specific antigen cross-reactivity. Urology 1998;51:804-809.
5. Darson MF, Pacelli A, Roche P, Rittenhouse HG, Wolfert RL, Young CYF, Klee GG, Tindall DJ, Bostwick DG: Human glandular kallikrein (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: A novel prostate cancer marker. Urology 1997;49:857-862.
6. Kumar A, Mikolajczyk SD, Goel AS, Millar LS, Saedi MS: Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2. Cancer Res 1997;57:3111-3114.
7. Takayama TK, Fujikawa K, Davie EW: Characterization of the precursor of prostate-specific antigen, activation by trypsin and by human glandular kallikrein. J Biol Chem 1997;272:21582-21588.
8. Kumar A, Goel AS, Hill TM, Mikolajczyk SD, Millar LS, Kuus-Reichel K, Saedi MS: Expression of human glandular kallikrein, hK2, in mammalian cells. Cancer Res 1996;56: 5397-5402.
9. Wang TJ, Linton HJ, Sokoloff RL, Grauer LS, Rittenhouse HG, Wolfert RL: Western blotting analysis of antibodies to prostate-specific antigen: Specificities for prostate-specific antigen and prostate-specific antigen fragments. Tumor Biol 1999;20(suppl 1):79-85.